COVID-19 in children and adolescents is associated with adverse long-term kidney outcomes, such as chronic kidney disease (CKD).

Pooled annual prevalence of GLP-1 RA use was 0.1 percent from 2018 to 2021 and increased to 0.4 percent by 2022.

(HealthDay News) — Prescribing medical cannabis to patients with chronic health conditions may improve health-related quality of life (HRQL), as well as some specific symptoms such as pain, fatigue, ...

16.9 percent of the association was mediated by psychological distress; 3.0 and 3.1 percent mediated by social isolation, neuroticism.

Urodynamics investigation to identify detrusor overactivity before proceeding to invasive overactive bladder treatments do not appear helpful.

In-hospital mortality in patients with AMI can be predicted with a risk-standardized model that includes patient factors, such as age and cardiogenic shock.

Semaglutide use associated with increased risk for NAION at the two-, three-, and four-year time point from the index date.

A nephrologist argues that advancing kidney care in the US requires tailored guidelines addressing ethnic diversity & fragmented healthcare.

Relevant risk for interaction seen with cardiac implantable electronic devices; no signs of cardiac damage seen during testing.

Study findings provide valuable clinical information for metastatic castration-sensitive prostate cancer (mCSPC) prognosis in routine clinical practice.

Compared to the general population, individuals with incident hospital-based cannabis use disorder care have an increased risk of death.

Many cancer patients prefer using telemedicine over in-person visits when completing the informed consent process, a study suggests.